NEW YORK – Tempus and Precision Health Informatics, the data insights business of the private independent practice Texas Oncology, said last week that they will partner to advance precision oncology research and personalized treatment decisions.
Within the collaboration, Precision Health Informatics will use Tempus' artificial intelligence-powered platform and genomic sequencing capabilities for clinical research and advancing personalized treatments. Tempus will also assist Precision Health Informatics in mining its database, which includes data from more than 55,000 cancer patients treated each year across Texas Oncology's 210 locations, for information and clinical insights to inform research into patient populations with unmet needs.
"This collaboration is about developing and connecting cancer patients to precise, effective treatment," Debra Patt, Texas Oncology's executive VP for public policy and strategic initiatives, said in a statement. "Leveraging data, Precision Health Informatics is at the forefront of precision medicine and its application to improving the standard of patient care."